Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Johnson & Johnson to buy surgery technologies developer Orthotaxy

Johnson & Johnson Medical Devices, via its French affiliate Apsis, has acquired software-enabled surgery technologies developer Orthotaxy for an undisclosed sum.

The acquisition is expected to support Johnson & Johnson in developing next-generation robotic-assisted surgery platform in orthopedics.

Established by Stéphane Lavallée, Orthotaxy is engaged in designing and development of computer-assisted platforms.

The firm is currently developing differentiated robotic-assisted surgery solution for total and partial knee replacement.

Johnson & Johnson intends to expand its application for a range of orthopaedic surgery procedures.

According to Johnson & Johnson, Orthotaxy’s technology will help to develop a complete orthopaedic solution that uses enabling technologies to personalize procedures and optimize surgery.

Johnson & Johnson’s orthopedics business DePuy Synthes Company group chairman Ciro R?mer said: “Our goal is to bring to market a robotic-assisted surgery technology that is an integral part of a comprehensive orthopaedics platform, delivering value to patients, physicians and healthcare providers across the episode of care.

“The team at Orthotaxy has significant expertise and passion in developing this platform, and we aspire to bring to market a differentiated technology that helps improve clinical outcomes and increases patient satisfaction.”

Johnson & Johnson Medical Devices Companies offer products, services, programs, and research and development capabilities in surgical technology, orthopedics and cardiovascular segments.

DePuy Synthes offers joint reconstruction, trauma, craniomaxillofacial and spinal surgery products, as well as sports medicine.

In October 2017, Johnson & Johnson Medical agreed to acquire German software firm Surgical Process Institute (SPI) for an undisclosed sum.

The German firm offers advanced software solutions to improve patient outcomes and operating room efficiency by reducing variability in surgical procedures.

SPI is specialized in the standardization and digitalization of surgical workflows in the operating theatre.

The company’s Surgical Procedure Manager (SPM) proprietary software solution enables better operating room utilization, in addition to resulting in consistent outcomes.


Image: Johnson & Johnson headquarters in New Brunswick, New Jersey. Photo: courtesy of Nikopoley.